Skip to content
  • Home
  • About Us
  • Industry Services
    • Cosmetics & Consumer Products
    • Pharmaceuticals
    • Biocides
    • Chemicals
    • Medical Devices
    • Food & Beverages
    • Next Generation Tobacco Products (NGTP) & E-Cigarettes
  • Contact us
  • Privacy Policy

  • Home
  • About Us
  • Industry Services
    • Cosmetics & Consumer Products
    • Pharmaceuticals
    • Biocides
    • Chemicals
    • Medical Devices
    • Food & Beverages
    • Next Generation Tobacco Products (NGTP) & E-Cigarettes
  • Contact us
  • Privacy Policy

Category: Pharmaceuticals

Therapeutic Goods Administration, Australia published an updated version of Appendix 1 – Established acceptable intake for nitrosamines in medicines

 36 nitrosamines AI limits added/revised. https://www.tga.gov.au/how-we-regulate/monitoring-safety-and-shortages/industry-information-about-specific-safety-alerts-recalls-and-shortages/nitrosamine-impurities-medicines/appendix-1-established-acceptable-intake-nitrosamines-medicines

by sagarvati August 7, 2024
Copyright 2024. All rights reserved. Owned by Sagarvati Scientific & Regulatory Consulting LLP